References
- Janes K, Calvo P, Alonso M. Polysaccharide colloidal particles as delivery systems for macromolecules. Adv Drug Deliv Rev. 2001;47(1):83–97.
- De Campos AM, Sanchez A, Alonso M. Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A. Int J Pharm. 2001;224(1–2):159–168.
- Xu Y, Du Y. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int J Pharm. 2003;250(1):215–226.
- Ilium L. Chitosan and its use as a pharmaceutical excipient. Pharma Res. 1998;15(9):1326–1331.
- Rajitha P, Gopinath D, Biswas R, et al. Chitosan nanoparticles in drug therapy of infectious and inflammatory diseases. Expert Opin Drug Deliv. 2016;13(8):1177–1194.
- Mohammed M, Mansell H, Shoker A, et al. Development and in vitro characterization of chitosan-coated polymeric nanoparticles for oral delivery and sustained release of the immunosuppressant drug mycophenolate mofetil. Drug Dev Ind Pharm. 2019;45(1):76–87.
- Nagpal K, Singh SK, Mishra DN. Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull. 2010;58(11):1423–1430.
- Hosseini SF, Soleimani MR, Nikkhah M. Chitosan/sodium tripolyphosphate nanoparticles as efficient vehicles for antioxidant peptidic fraction from common kilka. Int J Biol Macromol. 2018;111:730–737.
- Shaw LM, Korecka M, Venkataramanan R, et al. Mycophenolic acid pharmacodynamics and pharmacokinetics provide a basis for rational monitoring strategies. Am J Transplant. 2003;3(5):534–542.
- Patel P, Patel H, Panchal S, et al. Formulation strategies for drug delivery of tacrolimus: an overview. Int J Pharm Investig. 2012;2(4):169–175.
- He X, Smeets RL, Koenen HJ, et al. Mycophenolic acid-mediated suppression of human CD4+ T cells: more than mere guanine nucleotide deprivation. Am J Transplant. 2011;11(3):439–449.
- Reis A, Reinhard T, Sundmacher R, et al. [Mycophenolatemofetil in ocular immunological disorders. A survey of the literature with 3 case reports]. Klin Monbl Augenheilkd. 1998;213(5):257–261.
- Reis A, Spelsberg H, Reinhard T, et al. Beneficial effect of preoperative mycophenoiate mofetil in murine corneal transplantation. Transpl Int. 1999;12(5):341–345.
- Fan W, Yan W, Xu Z, et al. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surf B Biointerf. 2012;90:21–27.
- Pal SL, Jana U, Manna PK, et al. Nanoparticle: an overview of preparation and characterization. J Appl Pharma Sci. 2011;1(6):228–234.
- Garud A, Singh D, Garud N. Solid lipid nanoparticles (SLN): method, characterization and applications. Int Curr Pharm J. 2012;1(11):384–393.
- Ekambaram P, Sathali AAH, Priyanka K. Solid lipid nanoparticles: a review. Sci Rev Chem Commun. 2012;2(1):80–102.
- Zaman M, Sarfraz RM, Adnan S, et al. Development and in-vitro evaluation of once daily tablet dosage form of loxoprofen sodium. Trop J Pharm Res. 2015;14(9):1557–1563.
- Zaman M, Qureshi J, Ejaz H, et al. Oral controlled release drug delivery system and characterization of oral tablets; a review. Pak J Pharm Res. 2016;2(1):67–76.
- Mourdikoudis S, Pallares RM, Thanh NT. Characterization techniques for nanoparticles: comparison and complementarity upon studying nanoparticle properties. Nanoscale. 2018;10(27):12871–12934. German.
- Radu G-L, Truică G-I, Penu R, et al. Use of the Fourier transform infrared spectroscopy in characterization of specific samples. UPB Sci Bull B: Chem Mater Sci. 2012;74(4):137–148.
- Loganathan S, Valapa RB, Mishra RK, et al. Thermogravimetric analysis for characterization of nanomaterials. In: Thermal and rheological measurement techniques for nanomaterials characterization. Amsterdam (The Netherlands): Elsevier, 2017. p. 67–108.
- Amjad MW, Alotaibi N. Formulation and in vitro characterization of donepezil-loaded chitosan nanoparticles. J Pharma Res Int. 2020;32(10):10–16.
- Silvestro I, Francolini I, Di Lisio V, et al. Preparation and characterization of TPP-chitosan crosslinked scaffolds for tissue engineering. Materials. 2020;13(16):3577.
- Akbari M, Rahimi Z, Rahimi M. Chitosan/tripolyphosphate nanoparticles in active and passive microchannels. Res Pharma Sci. 2021;16(1):79.
- Qi L, Xu Z, Jiang X, et al. Preparation and antibacterial activity of chitosan nanoparticles. Carbohydr Res. 2004;339(16):2693–2700.
- Scheubel E, Adamy L, Cardot JM, et al. Use of a simple dissolution technique to assess generic formulation differences. Dissolution Technol. 2012;19(1):52–58.
- Zaman M, Hanif M, Shaheryar ZA. Development of tizanidine HCl-meloxicam loaded mucoadhesive buccal films: in-vitro and in-vivo evaluation. PLoS One. 2018;13(3):e0194410.
- Danhier F, Ansorena E, Silva JM, et al. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161(2):505–522.
- Klang V, Matsko NB, Valenta C, et al. Electron microscopy of nanoemulsions: an essential tool for characterisation and stability assessment. Micron. 2012;43(2–3):85–103.